Judge Strikes $235 Million Patent Infringement Verdict Against Teva

A Delaware judge threw out a 2017 decision that had Teva on the hook for more than $235 million over its generic for GlaxoSmithKline’s chronic heart failure and blood pressure drug Coreg (carvedilol).
Source: Drug Industry Daily